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A B S T R A C T
Infections due to Haemophilus inﬂuenzae result in tremendous global morbidity. The conjugated vaccines against
H. inﬂuenzae type b (Hib) have dramatically reduced the incidence of invasive Hib disease in the routine im-
munization of infants. The several proteins used as vaccine candidates for this pathogen, but they don't produce
eﬃcient immune in animal models against all strains of H. inﬂuenzae. This study aimed to determine the di-
versity of hpd gene nucleotide sequences of Iranian native clinical isolates of H. inﬂuenzae as a native vaccine
candidate compared to standard strains.
Twenty isolates of H. inﬂuenzae recovered from diﬀerent clinical specimens of patients admitted to Milad and
Imam Khomeini hospitals, Tehran, Iran. Then, isolates detected and identiﬁed as H. inﬂuenzae using biochemical
tests, and further conﬁrmation through omp6 gene PCR. The hpd gene was ampliﬁed by PCR using gene-speciﬁc
primers, and the amplicons digested with EcoR1. For four isolates, the Amplicon of hpd gene sequenced, and the
sequences aligned with sequences harbored in GenBank. Subsequently, sequences were submitted to the EMBL
site (http://www.ebi.ac.uk/embl/).
EcoR1 restriction enzyme pattern was the same among the 19 clinical isolates, and only one isolate was
diﬀerent. That diﬀerent one with 3 out of 19 isolates were sequenced. The results showed that the nucleotide
sequences and the deduced amino acid sequences for protein D in clinical isolates were highly conserved with
similarities> 95%.
In conclusion, regarding high similarity up to 99% in clinical isolates, protein D can be a novel vaccine
candidate against all types of H. inﬂuenza from Iran. This ﬁnding should be proved with more isolates, and also,
evaluate the immunological features of protein D in animal models.
1. Introduction
Haemophilus inﬂuenzae is a pleomorphic Gram-negative bacillus
found in the human upper respiratory tract. It causes invasive infec-
tions, such as bronchitis, otitis, pneumonia, meningitis, septicemia, and
epiglottitis (Fink and Geme, 2006). Isolates of H. inﬂuenzae can sub-
divide into two important forms; encapsulated and non-encapsulated
that serotype b causes meningitis, mainly in children below four years
of age (Resman et al., 2011). Nontypeable H. inﬂuenzae (NTHi) usually
is a commensal with the capability of producing infections of the upper
and lower respiratory tracts, such as sinusitis, bronchitis acute otitis
media, as well as, more infrequently, severe invasive infections such as
pneumonia, bacteremia, and meningitis (Clementi and Murphy, 2011;
Yamanaka, 2011).
Protein D (PD) is a highly conserved Lipoprotein in the outer
membrane of both typeable and non-typeable (NTHi) strains of H. in-
ﬂuenzae. PD is a feasible vaccine candidate against NTHi strains (Cripps
and Otczyk, 2006). Although PD is not an adhesion, it indirectly pro-
motes bacterial adhesion and invasion due to glycerophosphodiesterase
(GlpQ) activity and enhances bacterial colonization into human
monocytes (Clarke et al., 2017).
The studies showed that> 97% of the strains antigenic similarity
and 67% with glycerophosphodiesterase in Escherichia coli, and this
shows the PD has a domain periplasmic (1, 2). In addition, nucleotide,
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and deduced amino acid sequences were found to be highly homo-
logous hpd gene from NTHi (Behrouzi et al., 2017). The C-terminal
region, due to more selective pressure by the immune system of the host
can be variable than the N-terminal part (Behrouzi et al., 2017).
So, this study aimed to determine the diversity of hpd gene nu-
cleotide sequences of Iranian native clinical isolates of H. inﬂuenzae as a
native vaccine candidate compared to standard strains.
2. Methods
2.1. Study population
Patients admitted to Milad, Imam Khomeini hospitals, Tehran, Iran
included in the present study. The samples gathered from suspected
infection cases.
2.2. Source of isolates
A total of 20 isolates of H. inﬂuenzae originated from diﬀerent
samples, including blood, eyes, nasal secretions, throat, CSF collected
during a year (from August 2010 to 2011). All samples were cultured on
Stuart transport medium and shipped to the Department of
Bacteriology, Pasteur Institute of Iran, Tehran. Afterward with the
samples were cultured using by swabs on chocolate agar medium
containing 10% sterile sheep blood and then incubated for 24 to 48 h at
37 °C in a 5% CO2 incubator. Organisms were identiﬁed as H. inﬂuenzae
if they were small, pleomorphic, gram-negative rods on Gram stain, and
required supplemented with Vitox (Oxoid Ltd., Basingstoke,
Hampshire) for growth on Trypticase soy agar. The H. inﬂuenzae iso-
lates were serotyped by Hib-speciﬁc antiserum as described previously
(Kim et al., 2011; Satola et al., 2007). Stock cultures were maintained at
−70 °C in Trypticase Soy Broth with 20% Glycerol.
2.2.1. DNA extraction
The DNA of isolates was puriﬁed by QIAamp DNA mini kit (Qiagen,
Valencia, CA) according to manufacturer's instructions. Extraction of
bacteria harvested in the exponential growth phase after culturing on
chocolate agar at 37 °C in 5% CO2. The concentration of puriﬁed DNA
used as the standard for quantiﬁcation measured in a NanoDrop spec-
trophotometer (NanoDrop Technologies, Wilmington, DE).
2.2.2. PCR ampliﬁcation of the P6 gene
PCR ampliﬁcation was performed to detect the omp6 gene to con-
ﬁrm isolates as described by Saiki et al. performed (Lerner et al., 2007).
The length of the ampliﬁed products expected to size 351 bp. The se-
quences of oligonucleotides for the primers were as follows: Primer F;
5′-AAC TTT TGG CGG TTACTC TG-3′, and primer R; 5′-CTA ACA
CTGCAC GAC GGT TT-3′. The oligonucleotide sequences were synthe-
sized by Kurabo (Osaka, Japan).
2.2.2.1. PCR ampliﬁcation of the hpd gene. The primer set, hpd -F and
hpd -R, was designed based on the published DNA sequences in
GenBank (L15200.1) for the hpd gene, using Vector NTI Advanced
11.0. The length of the ampliﬁed products was expected to be 1095 bp.
The sequences of oligonucleotides for the primer set and probes were as
follows: Primer hpd -F, 204- ATG AAA CTT AAA ACT TTA GCC CTT TC-
230 (melting temperature, 56.89C); and primer R-1299 TTA TTT TAT
TCC TTT TAA GAA TTC CAC G-1272 (melting temperature, 55.71C).
The oligonucleotides were synthesized by Macrogen (Seoul, Korea).
2.2.2.1.1. Restriction fragment length analysis (RFLP). First, 6.5 mL
of samples was added to microtubes, then, 5mL deionized distilled
water, 6 mL product PCR, 1.5 mL restriction enzyme buﬀer, and 1 μL
restriction EcoR1 added and mix well (do not vortex). Next, Enzymes
incubated for 4 h at 37 °C (Del Rio et al., 2006). Finally, electrophoresis
was done on 2% agarose gel using low voltage 60 V.
2.3. Nucleotide sequencing
The PCR product of each restriction fragment pattern (RFLP) was
randomly chosen and was sequenced. Sequence analysis performed
with the Applied Biosystems Hitachi 3130 Genetic analyzer.
3. Results
Of the total clinical isolates, 30% (n= 6) were isolated from cere-
bral spinal ﬂuid (CSF) and Blood, 30% (n=6) from eye, 40% (n=8)
from throat, and nasopharynx. The ampliﬁcation of the hpd gene using
PCR produced a DNA fragment of approximately 1095 bp (Fig. 1).
Digestion products were resolved on 2% agarose gels and visualized
on a UV transilluminator after ethidium bromide staining. Molecular
weight markers were run to estimate fragment sizes (100-bp ladders).
Digestion of these fragments produced with EcoR1 Enzyme. All the
isolates except one produced a restriction pattern with two types of
fragments, one with 653 bp and another with a fragment of approxi-
mately 443 bp (Fig. 2).
To conﬁrm the validity of the RFLP analysis and to explore sequence
diﬀerences in RFLP pattern, we chose 1 diﬀerent (KC608170) with
Fig. 1. PCR ampliﬁcation of hpd gene H. inﬂuenzae from clinical isolates.
Fig. 2. RFLP analysis of PCR ampliﬁed hpd gene from the genomic DNA of
clinical isolates of H. inﬂuenzae.
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three other representative hpd genes sequenced. Sequence Alignment
hpd isolated from KC608170 with cases recorded in GeneBank
(GQ402000.1, GQ402008.1, and Z35656); respectively 92%, 98%, and
93% similarity were observed. In comparison, the mutant isolate with
isolates recorded in NCBI was found that have the diﬀerence in11
amino acids (Table 1).
4. Discussion
H. inﬂuenzae serotype b (Hib) is a signiﬁcant cause of bacterial
meningitis and other invasive infections among children younger than
four years. Since the vaccination against Hib, other stereotypes and
nontypeable strains have emerged as a signiﬁcant cause of H. inﬂuenzae
associated diseases (Bottomley et al., 2016).
It is transmitted by the respiratory tract from infected to susceptible
people. Although this microorganism exists globally the burden of Hib
disease was signiﬁcantly higher in developing countries (Izadnegahdar
et al., 2013).
Several eﬀective Hib vaccines against strains made, but these vac-
cines can protect children against infections associated with NTHi
(Bresee et al., 2004). A large study on several proteins, such as cell
surface and outer membrane proteins (OMP) has been conducted to
develop an eﬀective vaccine against Hib and NTHi (Cripps et al., 2002;
Green et al., 1993). In previous studies, a high homology between the
nucleotide and deduced amino acid sequences of EcoRI sites within the
hpd gene from H. inﬂuenzae strains was determined; so, they concluded
that there was only a limited diversity within the hpd gene. The C-
terminal end of protein D due to expose on the outside of the bacterium
is more variable than the N-terminal part due to avoid the immune
system (Janson et al., 1993; Song et al., 1995).
In this study, we determined the DNA sequence of the structural hpd
gene, and amino acids in four clinical isolates and compared with the
previously reported hpd sequences from NTHi strains included in NCBI.
These ﬁndings suggest that the hpd gene is conserved in terms of
antigenic and functionality, so it has high homology to stereotypes and
biotypes strains of H. inﬂuence belonging to various other countries.
Amino acids from KC608167, KC608168, and KC608168 strains were
similar together up to 99%, but the KC608170 strain was diﬀerent in
thirty-four amino acid from others. At 81 position, cysteine amino acid
converted proline and against it, proline in 85 position converted to
cysteine. Restriction site polymorphism was observed in KC608170
isolates. Hence, it reﬂects this isolate be diﬀerent from other native
strains. All of the mutations were non-synonymous and altered amino
acids in cutting enzyme sites.
The results showed that the nucleotide sequences and the deduced
amino acid sequences for protein D in clinical isolates were highly
conserved with similarities> 95%.
5. Conclusion
In conclusion, regarding high similarity up to 99% in clinical iso-
lates, protein D can be a novel vaccine candidate against all types of H.
inﬂuenza from Iran. This ﬁnding should be proved with more isolates,
and also, evaluate the immunological features of protein D in animal
models.
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Table 1
Comparison of nucleotide sequences of clinically isolated with Gene Bank da-
tabases.
Sample ID Accession number Max ident Accession Gene Bank
3 KC608167 98% GQ402004
GQ402006
6 KC608168 100% GQ402007
GQ402006
9 KC608169 99% GQ402004
GQ402007
10 KC608170 92% GQ402000
98% GQ402008
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